LASSBio-2052

LASSBio-2052 is a derivative of N-acylhydrazone with antitumor activity against hepatocellular carcinoma (HCC). LASSBio-2052 inhibits HCC cells HepG2 and Hep3B, with IC50 of 18 and 41 μM. LASSBio-2052 arrests the cell cycle at G2/M phase, through downregulation of FOXM1. LASSBio-2052 induces apoptosis in HCC cells.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • No. CAS: 2549160-15-6
  • Fòrmula: C23H20F3N3O3
  • Peso molecular:443.42
  • Almacenamiento:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Actividad biológica
  • Chemical Information
  • Pureza y Documentación
  • Referencias
  • Help & FAQs

Ver todos los productos específicos de isoformas DNA/RNA Synthesis

More
100 mg

Obtener un presupuesto En stock

Please select quantity
Amount: USD 0.00